- Home
- MOLN vs MX Comparison
MOLN vs MX Comparison
Compare MOLN & MX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- MX
- Stock Information
- Founded
- MOLN 2004
- MX 2003
- Country
- MOLN Switzerland
- MX South Korea
- Employees
- MOLN N/A
- MX N/A
- Industry
- MOLN
- MX Semiconductors
- Sector
- MOLN
- MX Technology
- Exchange
- MOLN Nasdaq
- MX Nasdaq
- Market Cap
- MOLN 218.1M
- MX 188.0M
- IPO Year
- MOLN 2021
- MX N/A
- Fundamental
- Price
- MOLN $5.31
- MX $3.74
- Analyst Decision
- MOLN Hold
- MX Strong Buy
- Analyst Count
- MOLN 1
- MX 2
- Target Price
- MOLN $4.50
- MX $7.50
- AVG Volume (30 Days)
- MOLN 40.7K
- MX 429.7K
- Earning Date
- MOLN 08-26-2024
- MX 10-30-2024
- Dividend Yield
- MOLN N/A
- MX N/A
- EPS Growth
- MOLN N/A
- MX N/A
- EPS
- MOLN N/A
- MX N/A
- Revenue
- MOLN $7,105,397.00
- MX $219,520,000.00
- Revenue This Year
- MOLN N/A
- MX $3.09
- Revenue Next Year
- MOLN $29.41
- MX $10.06
- P/E Ratio
- MOLN N/A
- MX N/A
- Revenue Growth
- MOLN N/A
- MX N/A
- 52 Week Low
- MOLN $3.32
- MX $3.71
- 52 Week High
- MOLN $12.70
- MX $8.16
- Technical
- Relative Strength Index (RSI)
- MOLN 45.05
- MX 31.02
- Support Level
- MOLN $5.67
- MX $3.72
- Resistance Level
- MOLN $6.24
- MX $4.00
- Average True Range (ATR)
- MOLN 0.37
- MX 0.23
- MACD
- MOLN -0.11
- MX -0.03
- Stochastic Oscillator
- MOLN 12.58
- MX 3.11
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About MX Magnachip Semiconductor Corporation
MagnaChip Semiconductor Corp designs and manufactures analog and mixed-signal semiconductor platform solutions for communications, Internet of Things applications, consumer, industrial and automotive applications. The company's product portfolio consists of large display solutions, mobile display solutions, sensor solutions, LED solutions, mobile solutions, and power conversions. The company operates in two segments namely Transitional Fab 3 foundry services and Standard products business. The company operates in Korea, Asia Pacific (other than Korea), United States and Europe.